SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/E86C31BF47DE4F9704B150237D4D6195FF0D64F4F74E638EDDC4E4160CC2579D6CF5DB80155AD029298106C996CB57A2>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/E86C31BF47DE4F9704B150237D4D6195FF0D64F4F74E638EDDC4E4160CC2579D6CF5DB80155AD029298106C996CB57A2
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/E86C31BF47DE4F9704B150237D4D6195FF0D64F4F74E638EDDC4E4160CC2579D6CF5DB80155AD029298106C996CB57A2
http://www.w3.org/2000/01/rdf-schema#comment
"QKI is a novel Cancer stem cells (CSC) inhibitor and impaired multiple oral CSC properties via partial repression of SOX2."
xsd:string
http://purl.uniprot.org/uniprot/#_BD90E0AC5C7372CFEDE15351F66447DA92A062308880E2E115EEE9FB54BA465C0ADC7F74913A30214B3F2BC9BBD3D848
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/E86C31BF47DE4F9704B150237D4D6195FF0D64F4F74E638EDDC4E4160CC2579D6CF5DB80155AD029298106C996CB57A2
http://purl.uniprot.org/uniprot/Q8WY44
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/E86C31BF47DE4F9704B150237D4D6195FF0D64F4F74E638EDDC4E4160CC2579D6CF5DB80155AD029298106C996CB57A2
http://purl.uniprot.org/uniprot/#_Q8WY44-mappedCitation-24918581
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/E86C31BF47DE4F9704B150237D4D6195FF0D64F4F74E638EDDC4E4160CC2579D6CF5DB80155AD029298106C996CB57A2